Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer
- PMID: 7989937
- DOI: 10.1200/JCO.1994.12.12.2621
Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer
Abstract
Purpose: To investigate the neuropsychologic effects of cranial irradiation (CRT), intrathecal methotrexate (IT-MTX), and systemic methotrexate (SYS-MTX) in a cohort of pediatric patients with cancer who had either received no, moderate, or high doses of these treatments alone or in various combinations.
Patient and methods: Data were collected on 120 pediatric cancer patients from a large variety of diagnostic groups. Patients completed a comprehensive neuropsychologic test battery designed to assess most areas of cognitive functioning. In analyzing cancer treatment effects, the following variables were statistically controlled: (1) age, (2) socioeconomic status (SES), (3) age at diagnosis, (4) months since both onset and cessation of CNS treatments, (5) time missed from schooling, and (6) presence/type of CNS cancer.
Results: CRT, largely in combination with IT-MTX, was significantly associated with deficits in several, primarily nondominant, hemispheric neuropsychologic functions, even after control and other treatment variables were addressed. This relationship was somewhat, but not highly, dose-dependent at CRT doses greater than approximately 18 Gy, at least over the first several years posttreatment. While there was statistically significant evidence for cognitive impairment, absence from school during treatment and age at diagnosis were more predictive of reading and spelling academic achievement than having received CRT. IT-MTX and SYS-MTX alone were not associated with significant degrees of neuropsychologic involvement.
Conclusion: CRT, especially when administered with IT-MTX, at currently used dosages was associated with significant neuropsychologic impairment in children. These impairments are most likely to be reflected in nonverbal intelligence, perceptual abilities, and susceptibility to distraction. IT-MTX and SYS-MTX did not result in a consistent pattern of cognitive deficit.
Similar articles
-
Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice.J Clin Oncol. 1995 Oct;13(10):2490-6. doi: 10.1200/JCO.1995.13.10.2490. J Clin Oncol. 1995. PMID: 7595698 Clinical Trial.
-
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.J Clin Oncol. 1992 May;10(5):810-7. doi: 10.1200/JCO.1992.10.5.810. J Clin Oncol. 1992. PMID: 1569453 Clinical Trial.
-
A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.Cancer. 1998 Jan 1;82(1):208-18. Cancer. 1998. PMID: 9428499 Clinical Trial.
-
[Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].Med Wieku Rozwoj. 2012 Apr-Jun;16(2):128-37. Med Wieku Rozwoj. 2012. PMID: 22971657 Review. Polish.
-
Neurocognitive effects of treatment for childhood cancer.Ment Retard Dev Disabil Res Rev. 2006;12(3):184-91. doi: 10.1002/mrdd.20110. Ment Retard Dev Disabil Res Rev. 2006. PMID: 17061287 Review.
Cited by
-
The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.J Hematol Oncol. 2011 Oct 13;4:42. doi: 10.1186/1756-8722-4-42. J Hematol Oncol. 2011. PMID: 21996369 Free PMC article. Clinical Trial.
-
Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.J Neurooncol. 2012 May;108(1):163-71. doi: 10.1007/s11060-012-0822-7. Epub 2012 Feb 16. J Neurooncol. 2012. PMID: 22350379
-
Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.J Pediatr Hematol Oncol. 2010 Mar;32(2):113-8. doi: 10.1097/MPH.0b013e3181c9af84. J Pediatr Hematol Oncol. 2010. PMID: 20098337 Free PMC article.
-
[Leukostasis and tumor lysis: important complications of hyperleukocytosis].Internist (Berl). 2013 Sep;54(9):1051-60. doi: 10.1007/s00108-013-3260-5. Internist (Berl). 2013. PMID: 23943008 German.
-
A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy.J Consult Clin Psychol. 2008 Jun;76(3):367-78. doi: 10.1037/0022-006X.76.3.367. J Consult Clin Psychol. 2008. PMID: 18540731 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials